The UAE has become the second country worldwide to approve Itvisma, a groundbreaking gene therapy for spinal muscular atrophy ...
U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and ...
Akhilesh Gaharwar, a biomedical engineer and one of the researchers on the project at Texs A&M, said they have found a way to ...
Doctors explain why vitamin D supplements may not work properly if your kidneys are unhealthy, and how kidney function ...
Quebec, Canada, December 20th, 2025, FinanceWireInternational clinician and integrative health researcher Oxana Ali has ...
Dubai, UAE: The Emirates Drug Establishment (EDE) has announced the approval of Itvisma™ (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular ...
Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.
Regulator approves Itvisma for adults and children aged two and above, positioning the UAE among the first countries globally to authorise the treatment for a wider age group ...
Emirates News Agency on MSN
UAE approves gene replacement therapy for new age group in spinal muscular atrophy patients
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
The "agile, powerful, lightweight," motorcycle has been "engineered to break limits," the architectural firm told Newsweek.
Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback